PODD vs XENE · P/E 34, rev $1.56B vs $2.55B cap
Insulet Corporation (PODD) versus Xenon Pharmaceuticals Inc (XENE) — a side-by-side from cached financials, not a winner call.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.
Latest reported PODD revenue for 2026-06-30 was $1.56B. Net income was $186.1M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Latest reported XENE revenue for 2026-06-30 was $0. Net income was -$213.0M. XENE currently screens at market cap $2.55B.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. XENE currently screens at market cap $2.55B.
Not investment advice. Open the PODD and XENE stock pages for the full models.
Not investment advice.